- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT04231461
Quality of Life After Cardiac Surgery (QUACS)
March 14, 2024 updated by: Papworth Hospital NHS Foundation Trust
During the last twenty years heart surgery has become safer and the number of patients having heart surgery has increased with more frail patients being offered increasingly complex surgery.
Heart operations often improve survival and quality of life (QoL), but that is not true for all patients.
Regarding survival, clinicians can measure the risk to life from having a heart operation and the risk to life from not quite precisely, but clinicians have little idea about the impact of heart operations on QoL, which is the outcome that patients care about most.
Clinicians are unable to provide patients with robust information on how an operation will affect their QoL.
This study will provide this information by analysing the data from patient questionnaires immediately before and after the procedure and monthly thereafter for 12 months.
Study Overview
Status
Recruiting
Conditions
Intervention / Treatment
Detailed Description
The Sponsor shall use existing questionnaires to measure QoL in patients having major heart surgery. QoL will be measured before the operation and monthly afterwards for 12 months in order to answer the following questions:
- How does having heart surgery affect the QoL immediately after the operation?
- How long does it take patients to return to the same quality of life they had before the surgery?
- How long does it take patients to regain any loss of quality of life due to the operation? Does quality of life improve thereafter?
- What proportion of patients will achieve a net benefit in QoL?
- Are there features that can predict who will benefit in terms of QoL and who will not? The Sponsor will use the data to develop an electronic calculator to enable quick and robust evaluation of the impact of heart surgery on the QoL of individuals. Patients will then be able to give truly informed consent and to decide if they wish have surgery based on a full knowledge of both surgical risk and the potential impact on QoL.
Study Type
Observational
Enrollment (Estimated)
8004
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Contact
- Name: Christine Mills
- Phone Number: 01223 639710
- Email: christine.mills@nhs.net
Study Contact Backup
- Name: Phil Noyes
- Phone Number: 01223 639159
- Email: p.noyes@nhs.net
Study Locations
-
-
Cambridgeshire
-
Cambridge, Cambridgeshire, United Kingdom, CB2 0AY
- Recruiting
- Royal Papworth Hospital
-
Contact:
- Jamie Pack
- Phone Number: 01223 639623
- Email: Jamie.Pack@nhs.net
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (Adult, Older Adult)
Accepts Healthy Volunteers
No
Sampling Method
Non-Probability Sample
Study Population
All adults able to understand the patient information sheet written in English.
Description
Inclusion Criteria:
- EuroSCORE II ≥ 3% or EuroSCORE logistic of ≥ 6%
- Patients undergoing routine/ urgent cardiac surgery
- Patients must have the ability to provide informed consent
Exclusion Criteria:
- Patients undergoing salvage or emergency operations
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Observational Models: Cohort
- Time Perspectives: Prospective
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Quality of Life using Questionnaire EQ-5D
Time Frame: 12 Months
|
Conduct questionnaire EQ-5D to assess Quality of Life Change post major cardiac surgery procedure.
These questionnaires ask patients to assess their levels of pain, mobility, anxiety and depression to give an overall Quality of Life Measure.
|
12 Months
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Quality of Life using Questionnaire SF-12
Time Frame: 12 Months
|
Conduct questionnaire SF-12 to assess Quality of Life Change post major cardiac surgery procedure.
These questionnaires ask patients to assess their levels of pain, mobility, anxiety and depression to give an overall Quality of Life Measure.
|
12 Months
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Change in Quality of Life using Questionnaire LOT
Time Frame: 12 months
|
Conduct questionnaire LOT to assess Quality of Life Change post major cardiac surgery procedure.
These questionnaires ask patients to assess their levels of pain, mobility, anxiety and depression to give an overall Quality of Life Measure.
|
12 months
|
Change in Quality of Life using Questionnaire PANAS
Time Frame: 12 months
|
Conduct questionnaire PANAS to assess Quality of Life Change post major cardiac surgery procedure.
These questionnaires ask patients to assess their levels of pain, mobility, anxiety and depression to give an overall Quality of Life Measure.
|
12 months
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Investigators
- Study Director: Samer Nashef, Chief Investigator Royal Papworth Hospital
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start (Actual)
July 19, 2019
Primary Completion (Estimated)
April 30, 2024
Study Completion (Estimated)
April 30, 2024
Study Registration Dates
First Submitted
September 12, 2019
First Submitted That Met QC Criteria
January 13, 2020
First Posted (Actual)
January 18, 2020
Study Record Updates
Last Update Posted (Actual)
March 15, 2024
Last Update Submitted That Met QC Criteria
March 14, 2024
Last Verified
March 1, 2024
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
- P02500
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
NO
IPD Plan Description
Participant data is not to be shared with researchers
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
No
Studies a U.S. FDA-regulated device product
No
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Aortic Valve Stenosis
-
Anteris Technologies Ltd.Active, not recruitingAortic Stenosis | Aortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisUnited States
-
The Medicines CompanyCompletedTranscatheter Aortic Valve Replacement | Aortic Valve Replacement | Severe Aortic StenosisNetherlands, Germany, United Kingdom, Canada, France, Italy, Switzerland
-
Anteris Technologies Ltd.Active, not recruitingAortic Valve Calcification | Severe Aortic Valve Stenosis | Symptomatic Aortic StenosisGeorgia
-
Ningbo Jenscare Biotechnology Co., Ltd.UnknownAortic Regurgitation | Severe Aortic Stenosis
-
Edwards LifesciencesActive, not recruitingAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
-
Edwards LifesciencesCompletedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Sorin Group USA, Inc.TerminatedAortic Valve Stenosis | Aortic Valve Stenosis With Insufficiency | Regurgitation, Aortic Valve | Aortic Valve IncompetenceUnited States
-
Hospices Civils de LyonRecruiting
-
Edwards LifesciencesActive, not recruitingHeart Failure | Aortic Stenosis | Mitral Valve Insufficiency | Aortic Valve Insufficiency | Mitral StenosisUnited States, Canada, Poland
-
Edwards LifesciencesCompletedAortic Stenosis | Aortic Regurgitation | Symptomatic Aortic StenosisChina
Clinical Trials on Cardiac Surgery
-
University of CalgaryRecruitingMinimally Invasive Cardiac Valvular SurgeryCanada
-
Aarhus University Hospital SkejbyTerminatedPain, Postoperative | Heart Surgery | Effusion Pleural | Chest TubeDenmark
-
Cardiovascular Research New BrunswickHorizon Health Network; Maritime Heart CentreActive, not recruitingObesity | Cardiac Disease | Cardiovascular Syndromes, MetabolicCanada
-
Coordinación de Investigación en Salud, MexicoUnknownStress HyperglycemiaMexico
-
Montreal Heart InstituteThe Montreal Health Innovations Coordinating Center (MHICC)CompletedPostoperative Complications | Acute Kidney Injury | Cardio-Renal Syndrome | C.Surgical Procedure; Cardiac | Right-Sided Heart FailureCanada
-
University of LiegeCompletedLow Cardiac Output Syndrome After Adult Cardiac Surgery
-
The Hospital for Sick ChildrenCompleted
-
RenJi HospitalRecruitingDelirium | Cognitive DysfunctionChina
-
University Hospital, EssenNot yet recruitingCardiac Surgery | Infective Endocarditis | OutcomesGermany
-
University of British ColumbiaRecruitingCardiovascular Diseases | Stroke, Acute | Stroke, Cardiovascular | Perioperative Complication | Stroke, ComplicationCanada